SEC Comment Letter 0000000000-25-002410 to CHAMPIONS ONCOLOGY, INC. (CSBR) (CIK 0000771856) (CSBR)
CHAMPIONS ONCOLOGY, INC. (CSBR) (CIK 0000771856)
Date: March 4, 2025 · CIK: 0000771856 · Accession: 0000000000-25-002410
AI Filing Summary & Sentiment
File numbers found in text: 001-11504
Letter
March 4, 2025 David Miller Chief Financial Officer Champions Oncology, Inc. One University Plaza Suite 307 Hackensack, New Jersey 07601 Re:Champions Oncology, Inc. Form 10-K for the Fiscal Year Ended April 30, 2024 Form 8-K dated December 11, 2024 File No. 001-11504 Dear David Miller: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
March 4, 2025
David Miller
Chief Financial Officer
Champions Oncology, Inc.
One University Plaza
Suite 307
Hackensack, New Jersey 07601
Re:Champions Oncology, Inc.
Form 10-K for the Fiscal Year Ended April 30, 2024
Form 8-K dated December 11, 2024
File No. 001-11504
Dear David Miller:
We have completed our review of your filings. We remind you that the company and
its management are responsible for the accuracy and adequacy of their disclosures,
notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences